Article
Pharma In brief - Canada: Patent For Esomeprazole Tablets Found Not To Be Obvious
AstraZeneca Canada Inc. and AstraZeneca AB ("AstraZeneca") brought an application pursuant to section 6 of the Patented Medicines (Notice of Compliance) Regulations for an order prohibiting the Minister of Health from issuing a Notice of Compliance to Ranbaxy Pharmaceuticals Canada Inc.
Norton Rose Fulbright Canada LLP
